Football Daily | Liverpool and their ‘blip’ that was the figment of a fevered imagination
Newcastle ‘summit meetings’ will finalise plans to strengthen Howe’s team
Liam Rosenior has taken Strasbourg up the table – and divided the fanbase | Luke Entwistle
Rudderless Chelsea’s sustained slump risks making Cole Palmer restless
A sense of acquiescence has pervaded Arsenal’s stuttering title challenge | Jonathan Wilson
Nice says more evidence needed on effectiveness of tirzepatide, sold under brand name Mounjaro
A weight-loss jab has been rejected for NHS use by England’s drugs watchdog.
The National Institute for Health and Care Excellence (Nice), which provides recommendations and guidance to health practitioners, said further evidence was needed on the clinical and cost-effectiveness of tirzepatide, which is sold under the brand name Mounjaro, before it could be recommended for NHS use.
More Stories
I became absorbed in strangers’ fertility journeys online
Microsoft unveils chip it says could bring quantum computing within years
Are noise-cancelling headphones impairing our hearing skills? Some audiologists are beginning to worry